Abbott, global health care company, is all set to preview the m2000, its new real-time PCR automated molecular diagnostic system, at the annual American Association for Clinical Chemistry (AACC) meeting in Chicago (July 23-27). Edward Michael, president of Abbott Molecular, said: The m2000 has been designed to help our customers deliver patient test results quickly and efficiently, with extremely accurate results. This innovative system represents our continued commitment to accelerate automation for the clinical molecular laboratory and improve the diagnosis, monitoring and care of patients with infectious diseases and other serious illnesses. The m2000 system comprises two instruments: the Abbott m2000sp and the m2000rt. It links an automated sample preparation instrument (m2000sp) with an integrated real-time PCR amplification and detection instrument (m2000rt) via software to provide automation from sample extraction to the reporting of the final test result. The robotic arm of m2000 eliminates steps such as manual pipetting, reducing hands-on time required to prepare samples for DNA/RNA testing by as much as 75 percent.
A study in the August issue of radiology reveals that the symptoms of depression can be reduced by inserting a stent to open a narrowed Carotid artery. Carotid stenosis is caused by the formation of plaque within the carotid artery, which supplies blood to the brain. The build-up of plaque narrows the opening in the artery and can lead to stroke. An interventional radiologist uses an image-guidance system such as computed tomography and a guide wire to reach the site of the narrowing in the artery, expands the artery with a balloon and inserts a stent to hold the artery open. The study’s lead author Wolfgang Mlekusch, M.D., specialist of clinical angiology and internal medicine at Vienna General Hospital and Medical School in Vienna, Austria said: The patients in this study who received carotid stenting showed significantly fewer depressive symptoms than those who did not. Our findings suggest that opening the carotid artery and restoring blood flow to the brain via a minimally invasive technique under local anesthesia is associated with significant reduction in depressive symptoms. We were able to demonstrate a clear neuropsychological benefit to patients after carotid stenting.